NCT02693535: TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Sponsor: American Society of Clinical Oncology. Phase: PHASE2. Conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors